Year Ended December 31,
(U.S. dollars in millions, except per share data)			2004			2003			2002
Net sales		$	25,168		$	22,165		$	13,882
Cost of goods sold (Notes 8 and 10)			(23,282	)		(20,860	)		(12,544	)
Gross profit			1,886			1,305			1,338
Selling, general and administrative expenses			(871	)		(691	)		(579	)
Gain on sale of soy ingredients business			–			111			–
Interest income			103			102			71
Interest expense			(214	)		(215	)		(176	)
Foreign exchange (loss) gain			(31	)		92			(179	)
Other income (expense)—net			31			19			6
Income from continuing operations before income tax and minority interest			904			723			481
Income tax expense			(289	)		(201	)		(104	)
Income from continuing operations before minority interest			615			522			377
Minority interest			(146	)		(104	)		(102	)
Income from continuing operations			469			418			275
Discontinued operations, net of tax benefit (expense)
	of $5 (2003) and $(1) (2002) (Note 3)		–			(7	)		3
Income before cumulative effect of change in accounting principles			469			411			278
Cumulative effect of change in accounting principles,
	net of tax benefit of $6 (2002) (Note 7 and 13)		–			–			(23	)
Net income		$	469		$	411		$	255
earnings per common share (note 24):
Basic
Income from continuing operations		$	4.42		$	4.19		$	2.87
Discontinued operations			–			(.07	)		.03
Cumulative effect of change in accounting principles			–			–			(.24	)
Net income per share		$	4.42		$	4.12		$	2.66
Diluted
Income from continuing operations		$	4.10		$	3.89		$	2.83
Discontinued operations			–			(.06	)		.03
Cumulative effect of change in accounting principles			–			–			(.23	)
Net income per share		$	4.10		$	3.83		$	2.63

The accompanying notes are an integral part of these consolidated financial statements.